ANIMATION

Gleevec (imatinib) MOA

Share this animation:

Kit is a receptor tyrosine kinase that activates of a number of pathways that direct cell proliferation, survival, and apoptosis. Mutations in Kit that result in constitutive oligomerization in the absence of ligand can drive continuous oncogenic signaling. The majority of gastrointestinal stromal tumor (GIST) cells have been found to present with overactive Kit signaling. Gleevec, or Glivec (imatinib mesylate) competitively binds to the ATP binding pocket of both active and inactive Kit, preventing downstream signaling. Kit inhibition by imatinib may induce both apoptosis and quiescence in KIT+ GIST cells.

Share It:
Contact XVIVO

Client


Novartis

XVIVO is top notch! I work with a lot of vendors on behalf of my clients and XVIVO exceeding my expectations every time. Not only was the work outstanding, the service was as well. Even when things got crazy, and they did several times, XVIVO delivered with a positive, can do it attitude – making my life and direct contact with the client much easier.

Account Director, Palio Communications
Share this animation: